2-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL)ACETONITRILE, 97.0%, 25g

2-(benzylamino)-2-cyclopropylacetic acid, 95.0%, 500mg

Hybridisation vial Non-coated, Height, 150 mm, 35 mm, 1 Piece

2-Chloro-3-(trifluoromethyl)aniline, 97.0%, 10g

(3-((Neopentyloxy)sulfonyl)phenyl)boronic acid, 95.0%, 1g

Pyrrolidin-3-ylmethanol hydrochloride, 95.0%, 25g

4-Amino-5-bromonicotinaldehyde, 95.0%, 250mg

2,2',3,3',5,5',6,6'-Octafluorobiphenyl>97.0%(GC)5g

2,3,4,5-Tetrahydrobenzo[f][1,4]oxazepine, 95.0%, 100mg

Benzoylthiocholine Iodide>98.0%(T)5g

1-Bromo-5-(bromomethyl)-2,4-difluorobenzene, 98%, 250mg

5-((3aS,4S,6aR)-2-Oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-N-(3,6,9,12-tetraoxapentadec-14-yn-1-yl)pentanamide, 95%, 1g

2-Cyclobutyl-2-phenylethan-1-amine hydrochloride, 97%, 500mg